' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 6 Researches
8.8
USERS' SCORE
Good
Based on 6 Reviews
8.2
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Vitamin D3 (as Cholecalciferol) (from Lanolin)
125 mcg (5,000 IU)
625%
Top Medical Research Studies
9
Vitamin D3 reduces BPPV recurrence
Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults.
Directly examines vitamin D effects
We investigated how supplementing vitamin D3 could affect the recurrence of Benign Paroxysmal Positional Vertigo (BPPV) in older adults. In a carefully designed double-blind clinical trial, we followed participants for 12 months to assess whether those treated with vitamin D3 would experience fewer BPPV episodes compared to those given a placebo.
Participants who were low on vitamin D3 received 13 weeks of a higher dose followed by a lower one, while others with sufficient levels were simply monitored. Our results were promising: the group receiving vitamin D3 experienced an impressive 87% reduction in recurrence rates and a significant delay in the time to first recurrence compared to the placebo group.
However, we didn't find any clear differences in outcomes between those treated with vitamin D3 and the participants who were already vitamin D replete. This trial provides a strong basis for further exploring vitamin D as a standard treatment option for BPPV in future research phases.
Participants who were low on vitamin D3 received 13 weeks of a higher dose followed by a lower one, while others with sufficient levels were simply monitored. Our results were promising: the group receiving vitamin D3 experienced an impressive 87% reduction in recurrence rates and a significant delay in the time to first recurrence compared to the placebo group.
However, we didn't find any clear differences in outcomes between those treated with vitamin D3 and the participants who were already vitamin D replete. This trial provides a strong basis for further exploring vitamin D as a standard treatment option for BPPV in future research phases.
Read More
9
Vitamin D improves BPPV recurrence
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Directly relates to vitamin D effects
We explored how treating severe vitamin D deficiency might affect the recurrence of benign paroxysmal positional vertigo (BPPV), a common cause of vertigo. BPPV is often tied to issues in the inner ear, and previous studies hinted at a link between vitamin D levels and this condition, yet none confirmed whether boosting vitamin D could actually lower recurrence rates.
In our study, we included participants diagnosed with unilateral, idiopathic posterior canal BPPV and a low level of vitamin D (25-hydroxyvitamin D3 ≤10 ng/ml). After initial assessments, including hearing tests and vitamin D levels, participants received vitamin D therapy. We rechecked their vitamin D levels three months later. Those whose levels improved significantly were in one group, and those who saw minimal improvement were in another.
Over the next 18 months of follow-up, we observed that those who managed to increase their vitamin D levels experienced a considerable decrease in BPPV recurrence. This suggests that improving vitamin D status can indeed be beneficial in managing this specific type of vertigo.
In our study, we included participants diagnosed with unilateral, idiopathic posterior canal BPPV and a low level of vitamin D (25-hydroxyvitamin D3 ≤10 ng/ml). After initial assessments, including hearing tests and vitamin D levels, participants received vitamin D therapy. We rechecked their vitamin D levels three months later. Those whose levels improved significantly were in one group, and those who saw minimal improvement were in another.
Over the next 18 months of follow-up, we observed that those who managed to increase their vitamin D levels experienced a considerable decrease in BPPV recurrence. This suggests that improving vitamin D status can indeed be beneficial in managing this specific type of vertigo.
Read More
8
Vitamin D3 improves BPPV symptoms
Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors.
Directly addresses BPPV treatment
We explored the impact of 1α-hydroxyvitamin D3 on patients suffering from benign paroxysmal positional vertigo (BPPV). The study included 50 BPPV patients who received daily doses of 0.25 µg of this vitamin, alongside their usual treatment. A control group of 50 other patients received standard treatment without any vitamin D3 supplementation.
By comparing various health markers before and after the treatment, we aimed to understand both the effectiveness of the vitamin and its potential role in managing vertigo symptoms. We observed notable improvements in bone mineral density among the treatment group, especially for both male and female patients, which highlights the substance’s positive effects.
The levels of vitamin D3 and relevant bone metabolic markers significantly increased, suggesting that not only does vitamin D3 play a role in improving BPPV symptoms, but it might also reflect on overall bone health. Our study indicated that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis are essential indicators of treatment effectiveness for BPPV patients.
By comparing various health markers before and after the treatment, we aimed to understand both the effectiveness of the vitamin and its potential role in managing vertigo symptoms. We observed notable improvements in bone mineral density among the treatment group, especially for both male and female patients, which highlights the substance’s positive effects.
The levels of vitamin D3 and relevant bone metabolic markers significantly increased, suggesting that not only does vitamin D3 play a role in improving BPPV symptoms, but it might also reflect on overall bone health. Our study indicated that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis are essential indicators of treatment effectiveness for BPPV patients.
Read More
Most Useful Reviews
10
Resolved vertigo issue
Worked wonders. I had very low vitamin D3 and suffered from severe vertigo and mild tinnitus. Within two months, both conditions improved, and by four months, they were gone. What a relief! No more spinning rooms or ringing bells. It's very inexpensive and effective.
Read More
9.5
Eased vertigo symptoms
This vitamin D supplement worked wonders for my vertigo. I bought it due to my lack of sunlight exposure, and it alleviated my dizziness as well as improved my sleep and mood. I will continue purchasing it!
Read More
0
Worsened vertigo symptoms
I’m not impressed with this brand. After taking the vitamin D3 supplement for three weeks, I experienced dizziness and vertigo. Upon stopping for two days, symptoms improved considerably. I do not recommend this brand.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 6 Researches
8.8
9.5
Vitamin D3 reduces vertigo recurrences
The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study.
Directly addresses vitamin D3 treatment
We explored how normalizing vitamin D levels could impact recurrent benign paroxysmal positional vertigo (BPPV) attacks. In this study, researchers conducted a case-control design that included patients who previously experienced multiple BPPV episodes and had low vitamin D levels.
Participants were divided into two groups: a treatment group that received weekly Vitamin D3 supplements, and a control group that did not. Both groups underwent Epley rehabilitation therapy over four weeks. After two months, the treatment group showed a significant increase in vitamin D levels while the control group did not see any change.
Remarkably, during the six-month follow-up, the treatment group experienced a dramatic reduction in BPPV attacks—about 15% had recurrences, compared to a staggering 96% in the control group. This suggests that there is a strong link between adequate vitamin D levels and a reduced risk of recurrent vertigo episodes.
This study highlights a potential breakthrough for those struggling with BPPV, indicating that maintaining healthy vitamin D levels may be a key component in preventing future vertigo episodes.
Participants were divided into two groups: a treatment group that received weekly Vitamin D3 supplements, and a control group that did not. Both groups underwent Epley rehabilitation therapy over four weeks. After two months, the treatment group showed a significant increase in vitamin D levels while the control group did not see any change.
Remarkably, during the six-month follow-up, the treatment group experienced a dramatic reduction in BPPV attacks—about 15% had recurrences, compared to a staggering 96% in the control group. This suggests that there is a strong link between adequate vitamin D levels and a reduced risk of recurrent vertigo episodes.
This study highlights a potential breakthrough for those struggling with BPPV, indicating that maintaining healthy vitamin D levels may be a key component in preventing future vertigo episodes.
Read More
9
Vitamin D3 reduces BPPV recurrence
Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults.
Directly examines vitamin D effects
We investigated how supplementing vitamin D3 could affect the recurrence of Benign Paroxysmal Positional Vertigo (BPPV) in older adults. In a carefully designed double-blind clinical trial, we followed participants for 12 months to assess whether those treated with vitamin D3 would experience fewer BPPV episodes compared to those given a placebo.
Participants who were low on vitamin D3 received 13 weeks of a higher dose followed by a lower one, while others with sufficient levels were simply monitored. Our results were promising: the group receiving vitamin D3 experienced an impressive 87% reduction in recurrence rates and a significant delay in the time to first recurrence compared to the placebo group.
However, we didn't find any clear differences in outcomes between those treated with vitamin D3 and the participants who were already vitamin D replete. This trial provides a strong basis for further exploring vitamin D as a standard treatment option for BPPV in future research phases.
Participants who were low on vitamin D3 received 13 weeks of a higher dose followed by a lower one, while others with sufficient levels were simply monitored. Our results were promising: the group receiving vitamin D3 experienced an impressive 87% reduction in recurrence rates and a significant delay in the time to first recurrence compared to the placebo group.
However, we didn't find any clear differences in outcomes between those treated with vitamin D3 and the participants who were already vitamin D replete. This trial provides a strong basis for further exploring vitamin D as a standard treatment option for BPPV in future research phases.
Read More
9
Vitamin D3 aids BPPV management
Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study.
Relevance due to combined treatment effect.
We explored how vitamin D3 supplementation may influence the intensity of benign paroxysmal positional vertigo (BPPV). This clinical trial specifically aimed to determine whether adding vitamin D3 to rehabilitation efforts—using Epley's maneuver—could enhance patient outcomes.
Our study involved patients diagnosed with BPPV through a thorough history and clinical examination. We evaluated the intensity of their vertigo symptoms using a simple visual analog scale, ranging from 0 to 10. We assessed vitamin D levels in participants, categorizing those with levels below 20 ng/ml as deficient. All of the patients received rehabilitation therapy once a week for a month.
We divided vitamin D deficient patients into two groups: those who received a weekly dose of vitamin D3 (50,000 IU) and those who did not. After two months, both groups showed a significant reduction in the intensity of their vertigo compared to a control group with sufficient vitamin D levels.
However, we observed that the improvement in the non-treated group eventually regressed back to baseline levels, while the group that received vitamin D3 maintained their improvement. This leads us to conclude that correcting vitamin D deficiency not only alleviates BPPV symptoms but also enhances the lasting effects of rehabilitation therapy.
Our study involved patients diagnosed with BPPV through a thorough history and clinical examination. We evaluated the intensity of their vertigo symptoms using a simple visual analog scale, ranging from 0 to 10. We assessed vitamin D levels in participants, categorizing those with levels below 20 ng/ml as deficient. All of the patients received rehabilitation therapy once a week for a month.
We divided vitamin D deficient patients into two groups: those who received a weekly dose of vitamin D3 (50,000 IU) and those who did not. After two months, both groups showed a significant reduction in the intensity of their vertigo compared to a control group with sufficient vitamin D levels.
However, we observed that the improvement in the non-treated group eventually regressed back to baseline levels, while the group that received vitamin D3 maintained their improvement. This leads us to conclude that correcting vitamin D deficiency not only alleviates BPPV symptoms but also enhances the lasting effects of rehabilitation therapy.
Read More
9
Vitamin D improves BPPV recurrence
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Directly relates to vitamin D effects
We explored how treating severe vitamin D deficiency might affect the recurrence of benign paroxysmal positional vertigo (BPPV), a common cause of vertigo. BPPV is often tied to issues in the inner ear, and previous studies hinted at a link between vitamin D levels and this condition, yet none confirmed whether boosting vitamin D could actually lower recurrence rates.
In our study, we included participants diagnosed with unilateral, idiopathic posterior canal BPPV and a low level of vitamin D (25-hydroxyvitamin D3 ≤10 ng/ml). After initial assessments, including hearing tests and vitamin D levels, participants received vitamin D therapy. We rechecked their vitamin D levels three months later. Those whose levels improved significantly were in one group, and those who saw minimal improvement were in another.
Over the next 18 months of follow-up, we observed that those who managed to increase their vitamin D levels experienced a considerable decrease in BPPV recurrence. This suggests that improving vitamin D status can indeed be beneficial in managing this specific type of vertigo.
In our study, we included participants diagnosed with unilateral, idiopathic posterior canal BPPV and a low level of vitamin D (25-hydroxyvitamin D3 ≤10 ng/ml). After initial assessments, including hearing tests and vitamin D levels, participants received vitamin D therapy. We rechecked their vitamin D levels three months later. Those whose levels improved significantly were in one group, and those who saw minimal improvement were in another.
Over the next 18 months of follow-up, we observed that those who managed to increase their vitamin D levels experienced a considerable decrease in BPPV recurrence. This suggests that improving vitamin D status can indeed be beneficial in managing this specific type of vertigo.
Read More
8
Vitamin D3 prevents vertigo recurrences
Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants.
Study highlights vitamin D3 effectiveness
We aimed to understand how vitamin D3 affects the recurrence of benign paroxysmal positional vertigo (BPPV), a common form of vertigo that can often come back after treatment. In our multi-center trial, we focused on patients with frequent BPPV episodes.
We divided 128 participants into three groups: one group received daily supplementation of vitamin D3 along with certain antioxidants and B vitamins, while the other two groups either received no supplements or only antioxidants, but all had sufficient vitamin D levels to start with.
Over six months, we observed a significant decrease in BPPV relapses among the group that was initially vitamin D deficient and which received the vitamin D3 along with other nutritional support. The results suggest that boosting vitamin D3 levels, as well as including antioxidants, can indeed help prevent recurring vertigo episodes for those who are lacking this essential vitamin.
We divided 128 participants into three groups: one group received daily supplementation of vitamin D3 along with certain antioxidants and B vitamins, while the other two groups either received no supplements or only antioxidants, but all had sufficient vitamin D levels to start with.
Over six months, we observed a significant decrease in BPPV relapses among the group that was initially vitamin D deficient and which received the vitamin D3 along with other nutritional support. The results suggest that boosting vitamin D3 levels, as well as including antioxidants, can indeed help prevent recurring vertigo episodes for those who are lacking this essential vitamin.
Read More
User Reviews
USERS' SCORE
Good
Based on 6 Reviews
8.2
10
Resolved vertigo issue
Worked wonders. I had very low vitamin D3 and suffered from severe vertigo and mild tinnitus. Within two months, both conditions improved, and by four months, they were gone. What a relief! No more spinning rooms or ringing bells. It's very inexpensive and effective.
9.5
Eased vertigo symptoms
This vitamin D supplement worked wonders for my vertigo. I bought it due to my lack of sunlight exposure, and it alleviated my dizziness as well as improved my sleep and mood. I will continue purchasing it!
8.8
Prevented vertigo recurrence
A neurologist suggested I take these capsules after experiencing vertigo. Thankfully, that condition hasn't returned since I started taking them.
8.8
Reduced vertigo attacks
I have a vitamin D3 deficiency and knee joint issues. This dosage has helped significantly with both. I take it every other day and it also helps lessen the frequency of my vertigo attacks. I’m pleased with the results.
8.8
Cleared vertigo completely
In six months, I've noticed significant improvement. My vertigo has cleared up, and although my knee joints are still crunchy, I feel back to normal and no longer require daytime sleep.
